
zzso is a novel zzso zzso system zzso zzso the combination therapy of zzso and zzso for blood pressure control have been reported zzso The primary objective of this analysis is to review recently reported zzso controlled trials zzso to compare zzso effects and adverse events between zzso zzso or zzso zzso and combination therapy of both zzso 

zzso for the search included zzso zzso and the Cochrane Central Register of Controlled zzso zzso zzso statistical program was used to analyze the zzso zzso mean differences zzso with a zzso confidence zzso zzso were used for the calculation of continuous data, and relative risk zzso with a zzso zzso was used for zzso zzso 

We analyzed the data from 7 zzso for a total of zzso participants in this zzso We found that the zzso combination therapy had a stronger effect in lowering blood pressure as compared with the zzso using zzso zzso zzso zzso zzso zzso zzso zzso zzso zzso zzso zzso zzso or zzso zzso zzso zzso zzso zzso zzso zzso zzso zzso zzso zzso zzso No differences were found in terms of adverse events between combination therapy and zzso except for the rates of peripheral zzso and zzso which were significantly lower in the combination therapy than in the zzso zzso zzso zzso zzso zzso zzso zzso Similar zzso effects were found in both obese zzso mass zzso zzso zzso and non-obese zzso mass index zzso zzso zzso zzso Moreover, there was no difference with the blood pressure lowering or adverse effects with regards to the combination therapy in both zzso 

We found that zzso combination therapy provided a more effective blood pressure reduction than zzso with either drug without increase in the occurrence of adverse zzso 

